Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BCS
BCS logo

BCS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Barclays PLC (BCS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
21.140
1 Day change
4.58%
52 Week Range
27.700
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Barclays PLC (BCS) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators show a bearish trend, options data reflects a neutral sentiment, and there are negative catalysts such as legal investigations and hedge fund selling. While some analysts maintain positive price targets, recent downgrades and lack of strong financial data make this stock less compelling for immediate investment.

Technical Analysis

The MACD is positive and expanding, but RSI is neutral at 40.186, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 20.057), indicating potential downside risk. Overall, the technical indicators suggest a bearish trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The implied volatility (IV) is high at 48.37 with an IV percentile of 89.64, suggesting elevated uncertainty. The put-call ratios indicate a slightly bullish sentiment, but the overall trading volume is low, reflecting limited investor interest.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
9

Positive Catalysts

  • Barclays is collaborating with Goldman Sachs and BNP Paribas to offer structured products, which may enhance its product portfolio. Analysts at Barclays predict strong S&P 500 performance, showing confidence in broader economic conditions.

Neutral/Negative Catalysts

  • The Rosen Law Firm is investigating Barclays for potential securities fraud, which could lead to reputational damage and financial penalties. Hedge funds have significantly increased their selling activity (233.56% rise in the last quarter). Barclays is tightening lending to smaller firms, which may impact its growth in certain segments.

Financial Performance

Financial data for the latest quarter is unavailable, making it difficult to assess the company's recent growth trends or profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst ratings are mixed. Erste Group downgraded the stock to Hold from Buy, and Citi lowered its price target to 450 GBp from 495 GBp. However, RBC Capital, JPMorgan, and Morgan Stanley raised their price targets earlier this year, maintaining Outperform or Overweight ratings. The overall sentiment appears cautious with a neutral bias.

Wall Street analysts forecast BCS stock price to rise
Analyst Rating
0
Wall Street analysts forecast BCS stock price to rise
Buy
Hold
Sell
0
Current: 21.160
sliders
Low
0
Averages
0
High
0
0
Current: 21.160
sliders
Low
0
Averages
0
High
0
Erste Group
Hans Engel
Buy
to
Hold
downgrade
AI Analysis
2026-03-05
Reason
Erste Group
Hans Engel
Price Target
AI Analysis
2026-03-05
downgrade
Buy
to
Hold
Reason
Erste Group analyst Hans Engel downgraded Barclays to Hold from Buy.
Citi
Andrew Coombs
Neutral
downgrade
$495 -> $450
2026-03-04
Reason
Citi
Andrew Coombs
Price Target
$495 -> $450
2026-03-04
downgrade
Neutral
Reason
Citi analyst Andrew Coombs lowered the firm's price target on Barclays to 450 GBp from 495 GBp and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BCS
Unlock Now

People Also Watch